Drug intelligence / Profile preview

arsenic

Development stage
Unknown
Lead developer
Teva Pharmaceutical Industries
Modality
Small Molecules
Administration
Intravenous, Oral, Topical
01

Overview

Arsenic is a naturally occurring metalloid element with the symbol As and atomic number 33. It exists in several allotropic forms and is found in both organic and inorganic compounds. Arsenic has a long history of medicinal use, particularly in traditional Chinese medicine for over two millennia, as well as notorious use as a poison. In modern medicine, certain arsenic compounds—most notably arsenic trioxide—are used to treat acute promyelocytic leukemia (APL) and other hematological malignancies due to their anti-tumor properties[4][7]. The mechanism of action involves disruption of cellular metabolism by binding to thiol groups on enzymes, inhibition of lipoic acid-dependent enzymes such as pyruvate dehydrogenase, interference with ATP production via uncoupling oxidative phosphorylation, induction of oxidative stress through increased hydrogen peroxide production, and promotion of apoptosis in malignant cells[5][4]. Arsenic is highly toxic; its toxicity depends on chemical form—with inorganic forms being more hazardous than organic ones—and dose. Chronic exposure can cause multisystem organ damage including skin lesions and cancer[1][8].

Other names
Asatomic number 33realgar (arsenic disulfide mineral)orpiment (arsenic trisulfide mineral)white arsenic (arsenic trioxide, As2O3)
02

Targets

DLAT (Dihydrolipoamide S-acetyltransferase)OGDH (Dihydrolipoamide S-succinyltransferase)

Beyond the preview

Go deeper on arsenic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on arsenic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call